Trames Bio Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

Trames Bio General Information

Description

Developer of gene therapy technologies designed for the treatment of neurological disorders and chronic pain conditions. The company includes engineered viral vectors, gene delivery technologies, and therapeutic constructs focused on regulating neuronal activity and targeted gene expression, enabling biotechnology and healthcare markets to develop precision therapies for neurological diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States
+1 (510)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1111 Broadway
  • Suite 1300
  • Oakland, CA 94607
  • United States
+1 (510)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Trames Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jun-2026 Completed Pre-Clinical Trials
To view Trames Bio’s complete valuation and funding history, request access »

Trames Bio Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Aditum Bio Venture Capital Minority
To view Trames Bio’s complete investors history, request access »

Trames Bio FAQs

  • When was Trames Bio founded?

    Trames Bio was founded in 2024.

  • Where is Trames Bio headquartered?

    Trames Bio is headquartered in Oakland, CA.

  • What industry is Trames Bio in?

    Trames Bio’s primary industry is Drug Discovery.

  • Is Trames Bio a private or public company?

    Trames Bio is a Private company.

  • What is Trames Bio’s current revenue?

    The current revenue for Trames Bio is .

  • Who are Trames Bio’s investors?

    Aditum Bio has invested in Trames Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process